Abstract: The present invention provides a stable pharmaceutical composition comprising gabapentin and pharmaceutically acceptable adjuvants, wherein the composition has an alkaline pH, and wherein at least one of the pharmaceutically acceptable adjuvants is a destabilizer.
| # | Name | Date |
|---|---|---|
| 1 | 762-mum-2003-wo international publication report(13-4-2006).pdf | 2018-08-09 |
| 2 | 762-mum-2003-specification(amended)-(28-9-2006).pdf | 2018-08-09 |
| 3 | 762-mum-2003-specification(amended)-(13-4-2006).pdf | 2018-08-09 |
| 4 | 762-mum-2003-form 5(3-8-2004).pdf | 2018-08-09 |
| 5 | 762-mum-2003-form 3(13-4-2006).pdf | 2018-08-09 |
| 6 | 762-mum-2003-form 2(title page)-(provisional)-(3-8-2003).pdf | 2018-08-09 |
| 7 | 762-mum-2003-form 2(title page)-(complete)-(3-8-2004).pdf | 2018-08-09 |
| 8 | 762-mum-2003-form 2(provisional)-(3-8-2003).pdf | 2018-08-09 |
| 9 | 762-mum-2003-form 2(complete)-(3-8-2004).pdf | 2018-08-09 |
| 10 | 762-mum-2003-form 18(5-10-2005).pdf | 2018-08-09 |
| 11 | 762-mum-2003-form 1(8-8-2003).pdf | 2018-08-09 |
| 12 | 762-mum-2003-form 1(4-8-2003).pdf | 2018-08-09 |
| 13 | 762-mum-2003-description(provisional)-(3-8-2003).pdf | 2018-08-09 |
| 14 | 762-mum-2003-description(complete)-(3-8-2004).pdf | 2018-08-09 |
| 15 | 762-mum-2003-correspondence(ipo)-(29-6-2010).pdf | 2018-08-09 |
| 16 | 762-mum-2003-correspondence(27-9-2006).pdf | 2018-08-09 |
| 17 | 762-mum-2003-claims(3-8-2004).pdf | 2018-08-09 |
| 18 | 762-mum-2003-cancelled pages(27-9-2006).pdf | 2018-08-09 |
| 19 | 762-mum-2003-abstract(3-8-2004).pdf | 2018-08-09 |